JN Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 94: 1104-1114, 2005; doi:10.1152/jn.00255.2005
0022-3077/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneda, K.
Right arrow Articles by Kita, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneda, K.
Right arrow Articles by Kita, H.

Synaptically Released GABA Activates Both Pre- and Postsynaptic GABAB Receptors in the Rat Globus Pallidus

Katsuyuki Kaneda1,2 and Hitoshi Kita1

1Department of Anatomy and Neurobiology, College of Medicine, University of Tennessee, Memphis, Tennessee; and 2The Japan Society for the Promotion of Science, Tokyo, Japan

Submitted 10 March 2005; accepted in final form 25 April 2005


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The globus pallidus (GP) contains abundant GABAergic synapses and GABAB receptors. To investigate whether synaptically released GABA can activate pre- and postsynaptic GABAB receptors in the GP, physiological recordings were performed using rat brain slice preparations. Cell-attached recordings from GABAA antagonist-treated preparations revealed that repetitive local stimulation induced a GABAB antagonist-sensitive pause in spontaneous firings of GP neurons. Whole cell recordings revealed that the repetitive stimulation evoked fast excitatory postsynaptic potentials followed by a slow inhibitory postsynaptic potential (IPSP) in GP neurons. The slow IPSP was insensitive to a GABAA receptor antagonist, increased in amplitude with the application of ionotropic glutamate receptor antagonists, and was suppressed by the GABAB antagonist CGP55845 The reversal potential of the slow IPSP was close to the potassium equilibrium potential. These results suggest that synaptically released GABA activated postsynaptic GABAB receptors and induced the pause and the slow IPSP. On the other hand, in the neurons that were treated to block postsynaptic GABAB responses, CGP55845increased the amplitudes of repetitive local stimulation-induced GABAA-mediated inhibitory postsynaptic currents (IPSCs) but not the ionotropic glutamate-mediated excitatory postsynaptic currents. Moreover, the GABAB receptor specific agonist baclofen reduced the frequency of miniature IPSCs without altering their amplitude distributions. These results suggest that synaptically released GABA also activated presynaptic GABAB autoreceptors, resulting in decreased GABA release in the GP. Together, we infer that both pre- and postsynaptic GABAB receptors may play crucial roles in the control of GP neuronal activity.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The globus pallidus (GP) of the rodent is the homologue of the external pallidal segment of the primate. The GP receives major GABAergic inputs from the striatum (Str) and neighboring GP neurons and major glutamatergic inputs from the subthalamic nucleus (STN) (Kita 1992Go, 1994Go; Kita and Kitai 1991Go; Parent and Hazrati 1995Go). The GP sends GABAergic outputs to many nuclei of the basal ganglia including the Str, STN, entopeduncular nucleus, and the substantia nigra (Bevan et al. 1998Go; Hazrati et al. 1990Go; Kita 1994Go; Kita and Kita 2001Go; Kita and Kitai 1994Go).

Studies have shown that GABAergic inputs play crucial roles in controlling GP neural activity (Kita 1992Go, 1994Go; Kita and Kitai 1991Go; Kita et al. 2004Go; Nambu and Llinás 1994Go). Although previous studies focused mainly on the ionotropic GABAA receptor-mediated actions, accumulating evidence suggests that metabotropic GABAB receptors may also be active in the GP. The expression of both the GABABR1 and GABABR2 subunits in the GP has been revealed by immunohistochemical and in situ hybridization studies in rat, monkey, and humans (Charara et al. 2000Go, 2004Go; Chen et al. 2004Go; Smith et al. 2000Go; Waldvogel et al. 2004Go). Electron microscopic analysis showed both pre- and postsynaptic expressions of GABAB receptors in the GP (Chen et al. 2004Go). In other brain areas, activation of postsynaptic GABAB receptors induces a slow hyperpolarization through the opening of potassium conductances and activation of receptors located at presynaptic terminals inhibits neurotransmitter release (Misgeld et al. 1995Go). In spite of these findings, electrophysiological studies investigating the functional roles of GABAB receptors in the GP are scarce (Chen and Yung 2003Go; Chen et al. 2002Go; Stefani et al. 1999Go). Because previous studies were performed using the exogenous application of the GABAB receptor agonist baclofen, it remains to be determined whether synaptically released GABA can activate GABAB receptors in the GP. In rat GP slices, single stimulation-induced inhibitory postsynaptic potentials and currents (IPSPs/IPSCs) were completely blocked by a GABAA receptor antagonist (Matsui and Kita 2003Go; Ogra and Kita 2000Go), suggesting very little or no involvement of GABAB receptors in the IPSPs/IPSCs induction. In other brain regions, repetitive stimulation is required to observe synaptically induced GABAB responses (Isaacson et al. 1993Go; Johnson et al. 1992Go; Mitchell and Silver 2000Go; Saitoh et al. 2004Go). Thus the aim of the present study was to investigate whether synaptically released GABA by repetitive stimulation can activate pre- and postsynaptic GABAB receptors in the GP using rat brain slice preparations.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Slice preparation

This study was performed in compliance with the National Institutes of Health Guide for Care and Use of Laboratory Animals. Sprague-Dawley juvenile rats (15–19 days old; 20–42 g) of both sexes were anesthetized with an intraperitoneal injection of a mixture of Ketamine (85 mg/kg) and Xylazine (15 mg/kg) and decapitated. The brains were rapidly removed and blocks containing the GP were obtained. Parasagittal slices (300–350 µm thick) were cut from the blocks on a vibrating blade microtome, Leica VT1000S (Leica Microsystems, Nussloch, Germany) in ice-cold oxygenated artificial cerebrospinal fluid (ACSF) containing (in mM) 126 choline chloride, 3 KCl, 1.24 NaH2PO4, 26 NaHCO3, 0.5 CaCl2, 6.3 MgSO4, 0.2 thiourea, 0.2 ascorbic acid, and 20 D-glucose, pH 7.4. The slices were then incubated in ACSF containing (in mM) 126 NaCl, 3 KCl, 1.24 NaH2PO4, 26 NaHCO3, 2.4 CaCl2, 1.3 MgSO4, and 10 D-glucose, pH 7.4 at 33°C for ≥1 h before recording.

Electrophysiological recordings

The slices were transferred to a recording chamber with oxygenated ACSF continuously perfused at a flow rate of 1–2 ml/min. The temperature of recording chamber was kept at 33 ± 1°C. Whole cell patch-clamp and cell-attached recording pipettes with a tip diameter of ~1.5 µm were pulled from 1.5 mm, thin-wall, borosilicate glass capillaries on a horizontal electrode puller (P-97; Sutter Instruments, Novato, CA). For the recording of GABAA-mediated IPSCs, the pipettes were filled with high-Cl electrolyte to increase the driving force of the IPSCs. The electrolyte contained (in mM) 90 K-gluconate, 50 KCl, 10 HEPES, 2 Mg-ATP, 0.3 Na-GTP, 0.2% Neurobiotin, and 3 QX-314 with the pH adjusted to 7.2 with KOH. The chloride equilibrium potential of the recorded neurons was estimated to be –26 mV by the Nernst equation when the cytoplasm of the neurons was fully equilibrated with 50 mM chloride. QX-314 was included to block action potential generation and postsynaptic GABAB responses (Andrade 1991Go; McLean et al. 1996Go; Nathan et al. 1990Go). For other recordings, the pipettes were filled with low-Cl electrolyte containing (in mM) 135 K-gluconate, 5 KCl, 10 HEPES, 2 Mg-ATP, 0.3 Na-GTP, and 0.2% Neurobiotin with the pH adjusted to 7.2 with KOH. The membrane potential recorded was corrected by the liquid junction potential of –10 mV. The resistance of these recording pipettes ranged from 4 to 8 M{Omega}. Neurons and recording pipettes were visualized using an infrared-differential interference contrast microscope BX50WI (Olympus, Tokyo), with a x40 water-immersion objective LUM Plan PL (Olympus) and a CCD camera (4990 series; COHU, San Diego, CA). Data were collected using an Axopatch 200B amplifier and AxoGraph 4.6 (Axon Instruments, Foster City, CA). Signals were filtered at 2 kHz, digitized at 5 kHz with a computer interface ITC-18 (InstruTECH, Port Washington, NY), and stored on the hard disc drive of a Macintosh G4 computer. For later off-line analysis, signals were also digitized and stored on a data recorder CDAT4 (Cygnus Technology, Delaware Water Gap, PA).

To evoke IPSPs/IPSCs or excitatory postsynaptic currents (EPSCs), a bipolar stimulating electrode with a tip distance of 0.2–0.3 mm was placed into the GP ~300 µm ventrocaudal to the recording neuron. In some experiments, the Str or the internal capsule (IC) was also stimulated. Electrical stimulation (200 µs in duration) with 2–50 pulses (usually 20 pulses) at 25–200 Hz (usually 50 Hz) was delivered through the bipolar electrode at 2–3-min intervals. To isolate GABAergic responses from glutamatergic ones, the N-methyl-D-aspartate (NMDA) receptor antagonist, 3-(2-carboxypiperzin-4-yl)-propyl-1-phosphonic acid (CPP, 30 µM), and the AMPA/kainate receptor antagonist, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxaline-7-sulfonamide (NBQX; 5–10 µM), were applied to the bath. To isolate EPSCs, the GABAA receptor antagonist gabazine (10 µM) was applied to the bath. To record action potential-independent miniature IPSCs (mIPSCs), tetrodotoxin (TTX; 1 µM) was applied to the bath in addition to the glutamate antagonists.

Histology

After recording, the slices were fixed overnight with a mixture of 4% paraformaldehyde and 0.2% picric acid. The fixed slices were rinsed several times with phosphate-buffered saline, incubated overnight with avidin-biotin-horseradish peroxidase complex (1% in buffered saline with 0.4% Trition X-100), rinsed, and then reacted with 3,3-diaminobenzidine. The slices were postfixed with 0.5% osmium tetroxide, dehydrated, infiltrated with a plastic resin, and mounted onto glass slides.

Data analysis and statistics

The amplitude of the slow IPSPs induced by repetitive stimulation was determined in the following manner. The peak of the slow IPSP occurred ~100 ms after the end of the repetitive stimulation. To suppress noise error, a mean response amplitude for a 200-ms period starting at the end of the stimulation was obtained from digitized data. This value was then subtracted from the mean prestimulus membrane potential for 5 s. We also normalized the amplitude of the slow IPSP by comparing the amplitude of the response to the amplitude of the current pulse injections. A current pulse (–10 pA, 300 ms) was injected 6 s prior to the stimulation to monitor the input resistance and the mean amplitude of the current pulse-induced response for the last 200 ms of the pulse was obtained. To obtain the normalized amplitude, the amplitude of the slow IPSP measured with the method described in the preceding text was divided by the amplitude of the current pulse-induced response.

mIPSCs were analyzed using the Mini Analysis Program (Synaptosoft, Decatur, GA). Events were ranked by amplitude and inter-event interval for the preparation of the cumulative probability distribution within 2-min epochs for control and drug conditions. The cumulative probability distributions were compared by the Kolmogorov-Smirnov test. All group data were expressed as means ± SD and analyzed statistically using the Student's t-test or an ANOVA with a post hoc Bonferroni test.

Chemicals

(R)-Baclofen, CGP52432 CGP55845 and (S)-(+)-{alpha}-amino-4-carboxy-2-methylbenzeneacetic acid (LY367385) were obtained from Tocris Cookson (Ellisville, MO). CPP, NBQX and gabazine (SR-95531) were obtained from Sigma-Aldrich RBI (St. Louis, MO). QX-314 was obtained from Alomone Labs (Jerusalem, Israel).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Repetitive local stimulation induced unitary responses of GP neurons

To verify the existence of GABAB receptor-mediated inhibition, unitary responses of GP neurons to repetitive local stimulation (20 pulses at 50 Hz) were recorded using the cell-attached recording technique. The neurons examined (n = 6) exhibited regular spiking activity (6–13 Hz). Repetitive local stimulation increased the firing rate of the action potentials during the stimulation in all six neurons examined (7.0 ± 2.7 Hz at prestimulation to 15.2 ± 4.5 Hz during stimulation, n = 6, P < 0.02, paired t-test). In four of the six neurons, the excitation was followed by a pause in the firing for 200–500 ms (Fig. 1A). The two remaining neurons responded with an excitation only. To isolate the GABAB receptor-mediated response, a mixture of the AMPA/kainate receptor antagonist NBQX (10 µM), the NMDA receptor antagonist CPP (30 µM), the GABAA receptor antagonist gabazine (10 µM), and the metabotropic glutamate receptor subtype 1 (mGluR1) antagonist LY367385 (10 µM) were applied. The antagonist mixture blocked the excitation and prolonged the duration of the pause but did not alter the basal firing activity of any neuron (8.9 ± 3.8 Hz in control and 8.4 ± 2.8 Hz in the antagonist mixture, n = 6, P > 0.7, paired t-test; Fig. 1B). An additional application of the GABAB receptor antagonist CGP55845(3 µM) completely blocked the prolonged pause (Fig. 1C). These results suggested that the pause was due to activation of postsynaptic GABAB receptors. To further characterize the GABAB receptor-mediated response, we performed the following experiments.



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 1. Repetitive local stimulation induced a GABAB blocker-sensitive pause in spontaneous firing in globus pallidus (GP) neurons. Spontaneous firings of GP neurons were recorded using a cell-attached configuration in a voltage-clamp mode. A: in standard artifical cerebrospinal fluid (ACSF), repetitive stimulation (20 pulses at 50 Hz, thick bar) induced an increase in the number of firings during the stimulation and a pause in firing immediately after the stimulation. B: bath application of a mixture of the AMPA/kainate receptor antagonist 1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM), the N-methyl-D-aspartate (NMDA) receptor antagonist 3-(2-carboxypiperzin-4-yl)-propyl-1-phosphonic acid (CPP, 30 µM), the GABAA receptor antagonist gabazine (10 µM), and the mGluR1 antagonist (S)-(+)-{alpha}-amino-4-carboxy-2-methylbenzeneacetic acid (LY367385, 50 µM) decreased the number of firings during the stimulation and increased the duration of the pause. C: an additional application of the GABAB receptor antagonist CGP55845(1 µM) completely blocked the pause. Similar results were obtained in 4 of the 6 neurons tested.

 
Repetitive stimulation induced slow IPSP

To characterize the GABAB receptor-mediated responses, whole cell patch-clamp recordings were performed. The neurons triggered repetitive firing without prominent spike accommodation on depolarizing current injection and had either prominent or moderate Ih-like sags on hyperpolarizing current injection, corresponding to both type A and B neurons reported by Cooper and Stanford (2000)Go and to the most numerous type in adult rodent GP (Kita and Kitai 1991Go; Nambu and Llinás 1994Go). Intracellular staining with Neurobiotin revealed that these neurons were of medium size and had fusiform- or multipolar-shaped somata with long, slowly tapering, smooth dendrites (data not shown).

Current-clamped neurons were continuously hyperpolarized (–65 to –72 mV) to prevent spontaneous spiking. The repetitive local stimulation (20 pulses at 50 Hz) induced fast excitatory postsynaptic potentials (EPSPs) with or without accompanying action potentials followed by fast inhibitory postsynaptic potentials (IPSPs) or slow IPSPs in the hyperpolarized neurons (Fig. 2A). In some neurons, these responses were followed by a small, slow depolarization. The slow depolarization was mediated in part by mGluR1 (unpublished observations). Application of gabazine (10 µM) eliminated the fast IPSPs, significantly increased the amplitudes of the fast EPSPs (Fig. 2D) and increased the number of the action potentials triggered by the EPSPs (Fig. 2B). Gabazine did not change the amplitude of the slow IPSPs (Fig. 2E). Additional application of NBQX (10 µM) and CPP (30 µM) abolished the fast EPSPs (Fig. 2, C and D) and significantly enhanced the amplitude of the slow IPSPs (Fig. 2, C and E). In 3 of 12 neurons tested, the slow IPSPs were undetected in control conditions but were observed after application of the antagonist mixture. The blockade of ionotropic glutamate receptors also caused a faster onset of the slow IPSPs. The latency of the slow IPSPs was 334.9 ± 185.7 ms in control and 152.2 ± 65.6 ms in the presence of gabazine, NBQX, and CPP (P < 0.05, paired t-test; n = 9).



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 2. Pharmacological isolation of slow inhibitory postsynaptic potentials (IPSPs). A: repetitive local stimulation (20 pulses at 50 Hz, thick bars) evoked fast excitatory postsynaptic potentials (EPSPs) with several action potentials followed by a slow IPSP in a GP neuron current-clamped at approximately –70 mV (->) in standard ACSF. B: bath application of gabazine (10 µM) increased the amplitude of the EPSPs and the number of action potentials triggered by the EPSPs. Gabazine did not change the amplitude of the slow IPSP in this neuron. C: an additional application of an NBQX (10 µM) and CPP (30 µM) mixture completely suppressed the EPSPs and, at the same time, shortened the onset and increased the duration of the slow IPSP. The action potentials and stimulus artifacts were truncated. D: a summary of the effects of GABAA and ionotropic glutamate receptor antagonists on normalized amplitudes of the fast EPSPs. Normalized amplitudes were obtained by dividing the amplitude of the fast EPSPs by the amplitude of the prestimulus test pulse (see METHODS for the detailed normalization procedure). Gabazine significantly increased the amplitude of the fast EPSPs, whereas an additional application of an NBQX and CPP mixture abolished the fast EPSPs. E: a summary of the effects of GABAA and ionotropic glutamate antagonists on the normalized amplitude of the slow IPSPs. Normalized amplitudes were obtained by the same methods as in D. Gabazine alone did not change the amplitude of the slow IPSPs, whereas an additional application of an NBQX and CPP mixture significantly increased the amplitude of the slow IPSPs.

 
The gabazine-insensitive slow IPSP was observed in 25 of 39 (64%) neurons. Morphological examinations revealed no differences in the somatic size and dendritic shape between the slow IPSP inducing and noninducing neurons (data not shown). With standard repetitive stimulation (100 µA, 20 pulses at 50 Hz), the slow IPSPs reached a peak at 518.7 ± 49.4 ms (n = 25) after the initiation of the stimulation with the amplitude ranging from –0.9 to –15.7 mV (–5.5 ± 4.2 mV; n = 25). The duration of the slow IPSPs, which was measured from the initiation of the stimulation, ranged from 0.9 to 2.4 s (1.4 ± 0.4 s; n = 25).

The induction of CGP55845sensitive slow IPSPs was also tested by repetitive stimulation of the Str and the IC. Although both Str and IC stimulation induced CGP55845sensitive slow IPSPs in GP neurons, the number of slow IPSP inducing neurons with the standard stimulation (100 µA, 20 pulses at 50 Hz) was lower for the Str (40%, n = 10) and slightly lower for the IC (61.4%, n = 102) as compared with GP stimulation. The slow IPSPs to IC stimulation were usually preceded by large fast EPSPs (data not shown).

Optimal stimulus condition to evoke slow IPSP

The optimal number and frequency of repetitive stimulations to evoke slow IPSPs were examined in five neurons that had been identified as being able to evoke slow IPSPs. The neurons were current-clamped at approximately –70 mV during recording in the ACSF containing the aforementioned glutamate and GABAA blockers. The mGluR1 receptor antagonist LY367385 (50 µM) was also included to suppress the slow depolarizations evoked in some neurons. In the first test, the number of stimulus pulses was increased stepwise from 2 to 50 or 100 with the standard stimulus frequency of 50 Hz and intensity of 100 µA. Stimulation with double pulses failed to evoke identifiable slow IPSPs in all neurons. The minimum, but also sufficient, stimulus pulse number needed to evoke distinct slow IPSPs was five. As the pulse number increased, the amplitude and duration of the responses increased (n = 5; Fig. 3A). Fifty pulse stimulations at 50 Hz evoked a nearly saturated response (Fig. 3, A and B). In the second test, the stimulus frequency was changed to a constant 10 pulses with an intensity of 100 µA. Three of the five neurons evoked the largest slow IPSPs by 50-Hz stimulation and remaining two neurons by 100-Hz stimulation (Fig. 3, C and D). The results indicated that the amplitude and the duration of the slow IPSPs were dependent on both the number and the frequency of stimulus pulses.



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 3. Optimal number and frequency of repetitive stimulations to evoke slow IPSPs. Slow IPSPs were induced by repetitive stimulation in 5 neurons current-clamped at approximately –70 mV (->) in the presence of NBQX (10 µM), CPP (30 µM), gabazine (10 µM), and LY367385 (50 µM). A: responses of a GP neuron to repetitive local stimulation with various pulse numbers. The number of stimulus pulses was increased stepwise from 2 to 100 with the frequency of 50 Hz and intensity of 100 µA. Identifiable slow IPSPs were evoked by 5 stimulations, and both the amplitude and the duration of slow IPSPs increased as the pulse number increased. The numbers on the left of each trace indicate the number of stimulus pulses. B: relative amplitudes of slow IPSPs, normalized by the largest slow IPSPs, evoked by stimulus with different number of pulses were plotted for 5 neurons. The stimulus with 50 pulses evoked nearly saturated slow IPSPs. C: responses of a GP neuron to repetitive local stimulation with various frequencies. The amplitude of the slow IPSPs was dependent on the stimulus frequency with the largest response at 100 Hz in this neuron. The numbers on the left of each trace indicate the frequencies of 10 repetitive stimulus pulses. Scale bars in A also apply to C. D: relative amplitudes of slow IPSPs, normalized by the largest slow IPSPs, evoked by different stimulus frequencies were plotted for 5 neurons. The largest slow IPSPs were observed with stimulus frequencies of 50 or 100 Hz.

 
GABAB receptors mediate the slow IPSPs

Examination of GABAB receptor antagonist effects on the pharmacologically isolated slow IPSPs was initiated with 3 µM CGP55845 the concentration expected to block GABAB receptors sufficiently according to a number of previous in vitro studies on other brain areas (Mott et al. 1999Go; Pham et al. 1998Go). CGP55845(3 µM) significantly suppressed the slow IPSPs (Fig. 4B). Application of 0.3 µM CGP55845also significantly inhibited the slow IPSPs (Fig. 4, A and B). The effects were not significantly different between the two concentrations (P > 0.05; Fig. 4B). In contrast, 0.03 µM CGP55845had no effect (Fig. 4B). CGP55845≤3 µM did not alter the membrane potential and the conductance. Application of another GABAB receptor-selective antagonist CGP52432(3 µM) also abolished the slow IPSPs (Fig. 4B). Application of TTX (1 µM) totally abolished the slow IPSPs (data not shown). These data suggested that the slow IPSPs induced by the repetitive local stimulation were due to the activation of postsynaptic GABAB receptors.



View larger version (14K):
[in this window]
[in a new window]
 
FIG. 4. GABAB receptors mediate the slow IPSPs evoked by repetitive local stimulation. A: response of a GP neuron to repetitive local stimulation (20 pulses at 50 Hz). The neuron was current-clamped at approximately –70 mV (->). The ACSF contained NBQX (10 µM), CPP (30 µM), gabazine (10 µM), and LY367385 (50 µM). Aa: repetitive stimulation induced a slow IPSP in control conditions. Ab: bath application of CGP55845(0.3 µM) blocked the slow IPSP and often revealed small, slow depolarizations (inset). Ac: a partial recovery from the CGP55845effect by washing. B: a summary of GABAB antagonists effects; 0.3 and 3 µM CGP55845 but not 0.03 µM, significantly inhibited the slow IPSP. The difference in the extent of the effects between 0.3 and 3 µM CGP55845was not statistically different (P > 0.05). CGP52432also blocked slow IPSPs. Because of the slow depolarizations, the slow IPSP amplitude measured during application of GABAB blockers was expressed as a negative value. The data are presented as means ± SD. **P < 0.01, ANOVA with post hoc Bonferroni test.

 
Potassium conductance is involved in the GABAB receptor-induced slow IPSPs

Recording from hyperpolarized neurons revealed that, in some neurons, repetitive stimulation evoked slow depolarizing responses that were resistant to the antagonists of ionotropic glutamate, GABAA receptors, and of mGluR1 (Figs. 4B and 5A). Because of the existence of pharmacologically unblockable slow depolarizing responses, the estimate of slow IPSP reversal potentials was performed in the following manner. First, we measured the amplitude of the slow IPSPs evoked at three different membrane potentials (–70, –90, and –110 mV, Fig. 5A). After application of CGP55845(3 µM), the same experiment was repeated. The CGP55845sensitive components of the slow responses were estimated by subtracting the corresponding responses (Fig. 5B). The reversal potential, estimated by plotting the holding potentials (Vh) versus the slow IPSP amplitudes, was –94.9 ± 6.6 mV (n = 5; Fig. 5, C and D), which was close to the potassium equilibrium potential (–101.3 mV) obtained by the Nernst equation.



View larger version (30K):
[in this window]
[in a new window]
 
FIG. 5. The reversal potential of slow IPSPs. A: the superimposed traces show responses of a GP neuron to repetitive local stimulation (20 pulses at 50 Hz) recorded before and after application of CGP55845(3 µM, CGP) with holding potentials of approximately –70, –90, and –110 mV. The ACSF contained NBQX (10 µM), CPP (30 µM), gabazine (10 µM), and LY367385 (50 µM). B: the CGP55845sensitive slow IPSPs (control–CGP) were obtained by subtracting CGP traces from the control traces at each holding potential. C: holding potential (Vh)–CGP55845-sensitive slow IPSP amplitude relationships of 5 neurons. D: averaged Vh–normalized CGP55845sensitive slow IPSP amplitude relationships. The response amplitude at each holding potential was normalized with the amplitude value at –70 mV. The reversal potential of the CGP55845sensitive slow IPSP was estimated to be –94.9 ± 6.6 mV (n = 5).

 
Synaptically released GABA activates presynaptic GABAB autoreceptors

GABAB receptors are localized on the GABAergic and glutamatergic presynaptic terminals as well as on postsynaptic elements in the rat GP (Chen et al. 2004Go). We examined whether synaptically released GABA can activate presynaptic GABAB receptors and control GABA release. The ACSF contained the ionotropic glutamate receptor blockers NBQX (10 µM) and CPP (30 µM). The GP neurons were voltage-clamped at –80 mV with electrodes filled with an electrolyte containing high-Cl and QX-314 (3 mM). QX-314 is known to inhibit the postsynaptic GABAB response as well as the sodium current (Andrade 1991Go; McLean et al. 1996Go; Nathan et al. 1990Go). To confirm the effect of QX-314 on the postsynaptic GABAB response, we examined the effects of baclofen (1–30 µM), a selective agonist of GABAB receptors, on the GP neurons. The neurons were voltage-clamped at –65 mV in the normal potassium concentration (3 mM). Bath application of baclofen dose-dependently elicited an outward current in all GP neurons recorded with the normal pipette solution (Fig. 6Aa). The effect of baclofen was saturated at 10 µM because 30 µM baclofen showed no further increase in the current amplitude (Fig. 6B). When the recordings were performed with pipettes containing 3 mM QX-314, 10 µM baclofen evoked significantly smaller outward currents (Fig. 6, Ab and B).



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 6. Intracellular injection of QX-314 inhibited the baclofen-induced outward current. A: responses to baclofen recorded in GP neurons. The neurons were voltage-clamped at –65 mV. The ACSF contained NBQX (10 µM), CPP (30 µM), and TTX (1 µM). Aa: when recordings were performed with the normal pipette electrolyte, bath application of baclofen induced an outward current in a dose-dependent manner with a saturated effect at 10 µM. Application of CGP55845(3 µM) suppressed the baclofen-induced current. Ab: when the recording pipettes contained QX-314 (3 mM), only a small outward current was induced by baclofen. B: a summary of baclofen-induced outward currents; 10 µM baclofen induced saturated responses. The amplitude of baclofen (10 µM)-induced current that was obtained with QX-314 (3 mM) containing pipettes (1.1 ± 3.6 pA, n = 8) was significantly smaller than that obtained with the normal pipette electrolyte (29.2 ± 17.9 pA, n = 5; P < 0.01).

 
To further minimize postsynaptic GABAB responses, the extracellular potassium concentration was elevated from 3 to 6.7 mM, which shifted the potassium equilibrium potential to approximately –80 mV as estimated by the Nernst equation. Under these conditions, the repetitive local stimulation (20 pulses at 50 Hz) evoked IPSCs (Fig. 7). Bath application of gabazine (10 µM) completely blocked the IPSCs. Moreover, an additional application of CGP55845(3 µM) had no effect (data not shown). These observations suggested that the responses were solely mediated by GABAA receptors and that the postsynaptic GABAB receptor-mediated response was completely suppressed under these recording conditions. As shown in Fig. 7A, the repetitive stimulation-induced IPSCs were summated and the onset point of each stimulus pulse coupled IPSC deviated from the base line especially during the latter part of the repetitive stimulation. We used the summated IPSC amplitude, measured from the base line to the peak of each IPSC as described in the Fig. 7B, for the analysis. To quantify the effect of CGP55845 we also determined the IPSC amplitude ratio by dividing the amplitude of each IPSC recorded in the presence of CGP55845by the amplitude of the corresponding IPSC in control. Bath application of 0.3 µM CGP55845significantly increased the amplitude of IPSCs from the fourth to the last stimulation (Fig. 7, C and D). Bath application of 3 µM CGP55845similarly increased the amplitude of the fast IPSCs in all four neurons (Fig. 7E).



View larger version (35K):
[in this window]
[in a new window]
 
FIG. 7. Blockade of presynaptic GABAB receptors increased the amplitudes of the repetitive stimulation-induced inhibitory postsynaptic currents (IPSCs) but not of the excitatory postsynaptic currents (EPSCs). A: repetitive local stimulation (20 pulses at 50 Hz) evoked IPSCs in a GP neuron before, during, and after bath application of 0.3 µM CGP55845 IPSCs were recorded with pipettes containing high-Cl and QX-314 (3 mM). QX-314 was included to block postsynaptic GABAB responses and sodium-dependent action potentials. The neurons were voltage-clamped at –80 mV. The ACSF contained NBQX (10 µM) and CPP (30 µM) in control conditions. The traces shown are averages of 2 successive trials separated by 3 min. B: an expanded trace of the control record in A to show the method of IPSC amplitude measurements. C: plots of IPSC amplitude vs. the stimulus pulse sequence for the neuron shown in A. CGP55845reversibly increased the amplitudes of the IPSCs. D: plots of IPSC amplitude ratios for 8 GP neurons tested with 0.3 µM CGP55845 The ratio was determined by dividing the IPSC amplitude in the presence of CGP55845by the amplitude of the corresponding control. The IPSCs evoked by the 4th to the last stimulation were significantly enhanced by CGP55845(*P < 0.05, **P < 0.01, ***P < 0.001; paired t-test). E: plots of IPSC amplitude ratios for 4 GP neurons tested with 3 µM CGP55845 The effects were very similar to those observed with 0.3 µM CGP55845 F: the EPSC amplitude ratios in the control and in the presence of CGP55845(3 µM) recorded in 5 neurons. CGP55845had no effect on the amplitudes of the repetitive local stimulation-induced EPSCs. For recordings of the EPSCs, the pipettes contained low-Cl and QX-314 (3 mM). The neurons were voltage-clamped at –80 mV in ACSF containing gabazine.

 
Synaptically released GABA failed to modulate EPSCs

We also examined whether the synaptically released GABA could modulate glutamate release by activating the GABAB receptors located on the glutamatergic axon terminals. The GP neurons were voltage-clamped at –80 mV with the electrodes filled with the low-Cl intracellular electrolyte including QX-314 (3 mM). To block the GABAA receptor-mediated IPSCs, gabazine (10 µM) was applied to the bath. Under these conditions, the repetitive stimulation (20 pulses at 50 Hz) delivered to the GP evoked EPSCs in GP neurons (n = 5; data not shown). In contrast to the augmenting effect of CGP55845on the IPSC amplitudes, CGP55845failed to affect the amplitudes of the EPSCs (Fig. 7F).

Effect of baclofen on miniature IPSCs

Finally, we examined the effects of the GABAB receptor agonist baclofen on TTX-insensitive miniature IPSCs (mIPSCs). mIPSCs were recorded in the presence of NBQX (10 µM), CPP (30 µM), and TTX (1 µM) using pipettes containing the high-Cl and QX-314 (3 mM). Gabazine (10 µM) application blocked the mIPSCs, confirming that they were mediated via GABAA receptors (data not shown). Neurons exhibiting relatively high-frequency mIPSCs were chosen for this experiment. Bath application of both 10 and 30 µM baclofen significantly reduced the mIPSCs frequency (Fig. 8, AD). The cumulative distributions of the inter-mIPSC intervals showed that baclofen significantly increased the width of the distribution curve (P < 0.01, Kolmogorov-Smirnov test, Fig. 8E). In either concentration, baclofen had no effect on the mean amplitude (Fig. 8G) or the amplitude distribution (Fig. 8F) of the mIPSCs. The effect of baclofen was blocked when CGP55845(3 µM) was co-applied with baclofen (Fig. 8D). Thus these results suggested that activation of the presynaptic GABAB receptors reduces the release of GABA.



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 8. Baclofen reduced the frequency but not the amplitude of miniature IPSCs (mIPSCs). A: sample traces show mIPSCs before and during baclofen application. mIPSCs were recorded with pipettes containing high-Cl and QX-314 (3 mM). The ACSF contained NBQX (10 µM), CPP (30 µM), and TTX (1 µM). The neurons were voltage-clamped at –65 mV. B and C: the frequency of mIPSCs was reduced by both 10 µM (n = 6; B) and 30 µM (n = 7; C) baclofen. The frequency was determined from 2 min of continuous recording. D: a summary graph shows that both 10 and 30 µM baclofen significantly reduced the frequency of mIPSCs (in 10 µM, 72.2 ± 17.3% of control, *P < 0.05; paired t-test; in 30 µM, 52.0 ± 10.5% of control, ***P < 0.001). The addition of CGP55845(3 µM) to the baclofen (30 µM) recovered the frequency of the mIPSCs (baclofen + CGP55845 86.5 ± 12.9% of control). The averaged data are presented as means ± SD. E: the cumulative distributions of the inter-mIPSC intervals obtained from a neuron show that baclofen (10 µM) significantly increased the width of the distribution curve (P < 0.01, Kolmogorov-Smirnov test). F: the cumulative amplitude distributions of mIPSCs recorded from 1 neuron show no amplitude shift with baclofen (10 µM; P > 0.5, Kolmogorov-Smirnov test). G: a summary graph shows that neither baclofen nor baclofen plus CGP55845affected the mean amplitude of the mIPSCs (in 10 µM, 99.5 ± 11.3% of control, P > 0.4; paired t-test; n = 6; in 30 µM, 94.0 ± 15.8% of control; P > 0.3; n = 7; in baclofen + CGP55845 94.2 ± 34.3% of control, P > 0.4; n = 7). The data are presented as means ± SD.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
The present study provides evidence, for the first time, that synaptically released GABA can activate both pre- and postsynaptic metabotropic GABAB receptors in the GP. Thus GABAB receptor-mediated synaptic mechanisms may contribute to the control of GP neuronal activity by both activating postsynaptic GABAB receptors that elicit slow IPSPs and by activating presynaptic receptors that suppress GABAergic transmissions.

Responses to intra-pallidal repetitive stimulation

Repetitive local stimulation evoked a series of fast EPSPs followed by a slow IPSP and, in some neurons, a slow depolarization. We are currently investigating the nature of the slow depolarization. Preliminary results suggest that the response is partially mediated by mGluR1 (unpublished observations). The fast EPSPs were glutamatergic and thus were considered to be due to the activation of glutamatergic afferents including those from the STN (Kita 1992Go, 1994Go; Kita and Kitai 1991Go; Parent and Hazrati 1995Go). Gabazine application significantly increased the amplitudes of the fast EPSPs, suggesting that GABAA-mediated IPSPs overlapped with the fast EPSPs. GABAA receptors are unlikely to be involved in the induction of the slow IPSP because gabazine did not affect the amplitudes of the slow IPSPs. In the presence of gabazine, the NBQX/CPP mixture augmented the amplitude and shortened the latency of the slow IPSPs. This suggests that the fast EPSPs partially overlapped with the slow IPSPs and decreased the amplitude of the slow IPSPs or that activation of ionotropic glutamate receptors at the synaptic terminals was suppressing the GABA release (Rodriguez-Moreno et al. 1997Go). Thus the slow IPSP induction was attributable to a direct activation of GABAergic axons that did not require glutamatergic activations in other intermediate neurons.

The finding that a repetitive stimulation of five pulses, delivered at 50 Hz, was required to evoke the slow IPSPs suggests that a relatively large amount or a prolonged release of GABA is necessary to effectively activate postsynaptic GABAB receptors. This is consistent with previous observations that a single stimulation of the Str evoked fast GABAA-mediated IPSPs/IPSCs but not GABAB-mediated responses in GP neurons (Matsui and Kita 2003Go; Ogra and Kita 2000Go). Similar requirements of repetitive stimulation for the induction of GABAB-mediated responses have been reported in other neurons (Johnson et al. 1992Go; Saitoh et al. 2004Go). The abundantly expressed GABA transporters in the GP might regulate the extent of GABAB receptor activation (Chen and Yung 2003Go; Ikegaki et al. 1994Go; Yasumi et al. 1997Go).

Postsynaptic GABAB responses

Intra-pallidal repetitive local stimulation was more effective in inducing slow IPSPs compared with Str and IC stimulation probably because it activated the local collateral axons and the striatal afferent axons more effectively. Unfortunately, the results obtained from Str and IC stimulation do not identify the origins of the GABAB responses. Stimulation of the Str activates both Str-GP and GP-Str axons along with its intra-pallidal collaterals (Kita and Kitai 1994Go; Ogura and Kita 2000Go). Similarly, stimulation of the IC activates the local collaterals and intra-pallidal collaterals of Str-entopeduncular/substantia nigra axons (Kita and Kitai 1994Go; Wu et al. 2000Go). Receptor localization studies suggest both striatal and local collateral synapses can evoke GABAB responses (Chen et al. 2004Go).

All repetitive stimulation at frequencies of 25–200 Hz could induce the slow IPSPs in GP neurons, although the most effective stimulus frequency was 50 or 100 Hz. The firing pattern of the major type of rat GP neurons in vivo is high frequency with pause and bursts (Gardiner and Kitai 1992Go; Kita and Kitai 1991Go; Magill et al. 2000Go; Ni et al. 2000Go). Thus it can be speculated that GABAB receptors in the GP would be sufficiently activated even with the spontaneous firing of GP neurons in vivo and be maximally activated by bursting activities. In contrast, projection neurons in rat Str are usually quiescent but show movement or task related activities of various intensities (Carelli et al. 1997Go; Gardiner and Kitai 1992Go; Wilson and Groves 1981Go). Thus the GABAB receptors associating with striatal synapses may be activated only when Str neurons were activated by strong cortical inputs.

The induction of postsynaptic GABAB responses requires intracellular GTP (Couve et al. 2000Go; Misgeld et al. 1995Go). When the cell-attached recordings were performed to preserve the intracellular milieu, repetitive stimulation induced a GABAB-mediated pause in spontaneous firings that had a similar duration to the slow IPSP. This finding suggests that the GTP contained in the pipette did not significantly alter the nature of postsynaptic GABAB responses.

The postsynaptic GABAB responses are mainly mediated by potassium conductances through the activation of G-protein-gated inwardly rectifying potassium (GIRK) channels (Jones et al. 1998Go; Kaupmann et al. 1998Go; White et al. 1998Go). Immunohistochemical and in situ hybridization studies suggested the expression of four subtypes of GIRK proteins and mRNAs in rodent GP neurons (Murer et al. 1997Go; Ponce et al. 1996Go; Wickman et al. 2000Go). In support of the functional expression of these channels, the reversal potential of the slow IPSP estimated in the present study was close to the potassium equilibrium potential as calculated by the Nernst equation. It is possible that the large variation in the amplitude of the GABAB response observed among GP neurons could be due to differences in the expression patterns of the GIRK channels in individual GP neurons.

Presynaptic GABAB responses

To study GABAB-mediated presynaptic modulations, the postsynaptic GABAB response was blocked by the intracellular injection of QX-314 (Andrade 1991Go; McLean et al. 1996Go; Nathan et al. 1990Go) and by the elevation of the extracellular potassium concentration that shifted the potassium equilibrium potential close to the holding membrane potential. These treatments were very effective as repetitive stimulation or baclofen application evoked no postsynaptic GABAB-mediated responses in these neurons. Under these conditions, the GABAB antagonist CGP55845increased the amplitudes of repetitive local stimulation-induced fast IPSCs, suggesting that synaptically released GABA activated presynaptic GABAB autoreceptors and decreased GABA release. Consistent with these findings, baclofen significantly reduced mIPSCs frequency without affecting their amplitudes.

The CGP55845induced increase of the fast IPSCs reached maximum at about five stimulus pulses, suggesting that a repetitive stimulation with five pulses at 50 Hz could fully activate presynaptic GABAB receptors. This was in contrast with evoking saturated-slow IPSPs that require a repetitive stimulation of ~50 pulses at 50 Hz. The possible reasons for the difference include that GABAB autoreceptors are largely localized at the main body of the synaptic specializations that are closest to GABA release site, while postsynaptic GABAB receptors are distributed more distantly (Chen et al. 2004Go). Different mechanisms between pre- and postsynaptic actions may also be involved. Possible presynaptic mechanisms for the reduction of GABA release include an activation of potassium conductance (Thompson and Gähwiler 1992Go) and a direct inhibition of Ca2+ entry and/or of the secretion process itself (Dittman and Regehr 1996Go; Takahashi et al. 1998Go; Thompson et al. 1993Go; Wu and Saggau 1997Go).

In contrast to the results of IPSCs amplitude modulation, the GABAB receptor blockade failed to affect the fast EPSCs; this is in agreement with the report by Hanson and Jaeger (2002)Go. Presynaptic GABAB receptors are localized at asymmetric synapses as well as at symmetric synapses in the rat GP, and the bath application of baclofen reduced the mEPSCs frequency without changing their amplitudes in GP neurons (Chen et al. 2002Go, 2004Go). Thus functional GABAB receptors might exist at the glutamatergic synapses. The failure of the GABAB antagonist to affect the amplitudes of evoked EPSCs under our recording conditions might be attributable to the difference in the distance between the GABA release sites and the location of presynaptic GABAB receptors. GABAB autoreceptors are largely localized at the main body of the synaptic specializations, whereas GABAB receptors at asymmetric synapses are mainly localized at perisynaptic sites (Chen et al. 2004Go). It is tempting to speculate that the autoreceptors and the GABAB receptors at asymmetric synapses might play different roles such as that the former operates in normal conditions and the latter in pathologic conditions such as Parkinson's disease in which a large number of pallidal neurons fire synchronously (Nini et al. 1995Go).

Functional implications

The results presented here imply that GABAB receptor actions contribute significantly to the control of the level and pattern of GP neuronal activity. Through pre- and postsynaptic GABAB receptors, GABAergic inputs with various strengths might dynamically modulate GP neuron activity. For instance, when prolonged high-frequency repetitive activation of GABAergic terminals takes place, released GABA would activate both post- and presynaptic GABAB receptors, the former inducing slow IPSPs and the latter leading to the suppression of GABAergic transmission. These actions would dampen GABAA-mediated actions following the burst inputs. On the other hand, a short bursting activity of GABAergic terminals would mainly dampen the succeeding GABA release.

The present findings also have implications for our understanding of the rhythmic activities generated by the GP-STN network in normal and pathophysiological conditions such as Parkinson's disease (Bevan et al. 2002bGo). Rhythmic activities could be induced by both cortical excitatory and pallidal inhibitory synaptic inputs and could be supported or enhanced by membrane properties of these neurons and also by the reciprocal connections between the GPe and STN (Bevan et al. 2002bGo; Magill et al. 2000Go, 2004Go). High-frequency firing of some GP neurons would induce GABAB-mediated slow IPSPs in both GP (present finding) and STN neurons (N. E. Hallworth and M. D. Bevan, personal communication). The slow IPSP in the GP neurons may disinhibit postsynaptic STN neurons. In addition, the slow IPSP evoked in the STN neurons may be followed by rebound burst firings (Bevan et al. 2000Go, 2002aGo ). The bursting activities in the STN neurons might, in turn, cause burst firings in recipient GP neurons. Taken together, these GABAB-contributed feedforward and feedback mechanisms might be involved, at least in part, in the rhythm generation in the GP-STN network.


    GRANTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
This work was supported by National Institute of Neurological Disorders and Stroke Grants NS-42762 and NS-47085 and by the Japan Society for the Promotion of Science.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: H. Kita, Dept. of Anatomy and Neurobiology, College of Medicine, The University of Tennessee Memphis, 855 Monroe Ave., Memphis, TN 38163 (E-mail: hkita{at}utmem.edu)


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Andrade R. Blockade of neurotransmitter-activated K+ conductance by QX-314 in the rat hippocampus. Eur J Pharmacol 199: 259–262, 1991.[CrossRef][Web of Science][Medline]

Bevan MD, Booth PAC, Eaton SA, and Bolam JP. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci 18: 9438–9452, 1998.[Abstract/Free Full Text]

Bevan MD, Magill PJ, Hallworth NE, Bolam JP, and Wilson CJ. Regulation of the timing and pattern of action potential generation in rat subthalamic neurons in vitro by GABAA IPSPs. J Neurophysiol 87: 1348–1362, 2002a.[Abstract/Free Full Text]

Bevan MD, Magill PJ, Terman D, Bolam JP, and Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 25: 525–531, 2002b.[CrossRef][Web of Science][Medline]

Bevan MD, Wilson CJ, Bolam JP, and Magill PJ. Equilibrium potential of GABAA current and implications for rebound burst firing in rat subthalamic neurons in vitro. J Neurophysiol 83: 3169–3172, 2000.[Abstract/Free Full Text]

Carelli RM, Wolske M, and West MO. Loss of lever press-related firing of rat striatal forelimb neurons after repeated sessions in a lever pressing task. J Neurosci 17: 1804–1814, 1997.[Abstract/Free Full Text]

Charara A, Galvan A, Kuwajima M, Hall RA, and Smith Y. An electron microscope immunocytochemical study of GABAB R2 receptors in the monkey basal ganglia: a comparative analysis with GABAB R1 receptor distribution. J Comp Neurol 476: 65–79, 2004.[CrossRef][Web of Science][Medline]

Charara A, Heilman TC, Levey AI, and Smith Y. Pre- and postsynaptic localization of GABAB receptors in the basal ganglia in monkeys. Neuroscience 95: 127–140, 2000.[CrossRef][Web of Science][Medline]

Chen L, Boyes J, Yung WH, and Bolam JP. Subcellular localization of GABAB receptor subunits in rat globus pallidus. J Comp Neurol 474: 340–352, 2004.[CrossRef][Web of Science][Medline]

Chen L, Chan SCY, and Yung WH. Rotational behavior and electrophysiological effects induced by GABAB receptor activation in rat globus pallidus. Neuroscience 114: 417–425, 2002.[CrossRef][Web of Science][Medline]

Chen L and Yung WH. Effects of the GABA-uptake inhibitor tiagabine in rat globus pallidus. Exp Brain Res 152: 263–269, 2003.[CrossRef][Web of Science][Medline]

Cooper AJ and Stanford IM. Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neuron in vitro. J Physiol 527: 291–304, 2000.[Abstract/Free Full Text]

Couve A, Moss SJ, and Pangalos MN. GABAB receptors: a new paradigm in G protein signaling. Mol Cell Neurosci 16: 296–312, 2000.[CrossRef][Web of Science][Medline]

Dittman JS and Regehr WG. Contributions of calcium-dependent and calcium-independent mechanisms to presynaptic inhibition at a cerebellar synapse. J Neurosci 16: 1623–1633, 1996.[Abstract/Free Full Text]

Gardiner TW and Kitai ST. Single-unit activity in the globus pallidus and neostriatum of the rat during performance of a trained head movement. Exp Brain Res 88: 517–530, 1992.[Web of Science][Medline]

Hanson JE and Jaeger D. Short-term plasticity shapes the response to simulated normal and parkinsonian input patterns in the globus pallidus. J Neurosci 22: 5164–5172, 2002.[Abstract/Free Full Text]

Hazrati LN, Parent A, Mitchell S, and Haber SN. Evidence for interconnections between the two segments of the globus pallidus in primates: a PHA-L anterograde tracing study. Brain Res 533: 171–175, 1990.[CrossRef][Web of Science][Medline]

Ikegaki N, Saito N, Hashima M, and Tanaka C. Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry. Brain Res Mol Brain Res 26: 47–54, 1994.[Medline]

Isaacson JS, Solis JM, and Nicoll RA. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 10: 165–175, 1993.[CrossRef][Web of Science][Medline]

Johnson SW, Mercuri NB, and North RA. 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons. J Neurosci 12: 2000–2006, 1992.[Abstract]

Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA, and Gerald C. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2. Nature 396: 674–679, 1998.[CrossRef][Medline]

Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A, and Bettler B. GABAB-receptor subtypes assemble into functional heteromeric complexes. Nature 396: 683–687, 1998.[CrossRef][Medline]

Kita H. Responses of globus pallidus neurons to cortical stimulation: intracellular study in the rat. Brain Res 589: 84–90, 1992.[CrossRef][Web of Science][Medline]

Kita H. Physiology of two disynaptic pathways from the sensorimotor cortex to the basal ganglia out nuclei. In: The Basal Ganglia. IV, edited by Percheron G, McKenzie JS, Féger J. New York: Plenum, 1994, p. 263–276.

Kita H and Kita T. Number, origins, and chemical types of rat pallidostriatal projection neurons. J Comp Neurol 437: 438–448, 2001.[CrossRef][Web of Science][Medline]

Kita H and Kitai ST. Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res 564: 296–305, 1991.[CrossRef][Web of Science][Medline]

Kita H and Kitai ST. The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain Res 636: 308–319, 1994.[CrossRef][Web of Science][Medline]

Kita H, Nambu A, Kaneda K, Tachibana Y, and Takada M. Role of ionotropic glutamatergic and GABAergic inputs on the firing activity of neurons in the external pallidum in awake monkeys. J Neurophysiol 92: 3069–3084, 2004.[Abstract/Free Full Text]

Magill PJ, Bolam JP, and Bevan MD. Relationship of activity in the subthalamic nucleus-globus pallidus network to cortical electroencephalogram. J Neurosci 20: 820–833, 2000.[Abstract/Free Full Text]

Magill PJ, Sharott A, Bolam JP, and Brown P. Brain state-dependence of coherent oscillatory activity in the cerebral cortex and basal ganglia of the rat. J Neurophysiol 92: 2122–2136, 2004.[Abstract/Free Full Text]

Matsui T and Kita H. Activation of group III metabotropic glutamate receptors presynaptically reduces both GABAergic and glutamatergic transmission in the rat globus pallidus. Neuroscience 122: 727–737, 2003.[CrossRef][Web of Science][Medline]

McLean HA, Caillard O, Khazipov R, Ben-Ari Y, and Gaiarsa JL. Spontaneous release of GABA activates GABAB receptors and controls network activity in the neonatal rat hippocampus. J Neurophysiol 76: 1036–1046, 1996.[Abstract/Free Full Text]

Misgeld U, Bijak M, and Jarolimek W. A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 46: 423–462, 1995.[CrossRef][Web of Science][Medline]

Mitchell SJ and Silver RA. GABA spillover from single inhibitory axons suppresses low-frequency excitatory transmission at the cerebellar glomerulus. J Neurosci 20: 8651–8658, 2000.[Abstract/Free Full Text]

Mott DD, Li Q, Okazaki MM, Turner DA, and Lewis DV. GABAB-receptor-mediated currents in interneurons of the dentate-hilus border. J Neurophysiol 82: 1438–1450, 1999.[Abstract/Free Full Text]

Murer G, Adelbrecht C, Lauritzen I, Lesage F, Lazdunski M, Agid Y, and Raisman-Vozari R. An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain. Neuroscience 80: 345–357, 1997.[CrossRef][Web of Science][Medline]

Nambu A and Llinás R. Electrophysiology of globus pallidus neurons in vitro. J Neurophysiol 72: 1127–1139, 1994.[Abstract/Free Full Text]

Nathan T, Jensen MS, and Lambert JD. The slow inhibitory postsynaptic potential in rat hippocampal CA1 neurons is blocked by intracellular injection of QX-314. Neurosci Lett 110: 309–313, 1990.[CrossRef][Web of Science][Medline]

Ni Z, Bouali-Benazzouz R, Gao D, Benabid AL, and Benazzouz A. Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci 12: 4338–4344, 2000.[CrossRef][Web of Science][Medline]

Nini A, Feingold A, Slovin H, and Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J Neurophysiol 74: 1800–1805, 1995.[Abstract/Free Full Text]

Ogura M and Kita H. Dynorphin exerts both postsynaptic and presynaptic effects in the globus pallidus of the rat. J Neurophysiol 83: 3366–3376, 2000.[Abstract/Free Full Text]

Parent A and Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20: 128–154, 1995.[CrossRef][Medline]

Pham TM, Nurse S, and Lacaille JC. Distinct GABAB actions via synaptic and extrasynaptic receptors in rat hippocampus in vitro. J Neurophysiol 80: 297–308, 1998.[Abstract/Free Full Text]

Ponce A, Bueno E, Kentros C, Vega-Saenz de Miera E, Chow A, Hillman D, Chen S, Zhu L, Wu MB, Wu X, Rudy B, and Thornhill WB. G-protein-gated inward rectifier K+ channel proteins (GIRK1) are present in the soma and dendrites as well as in nerve terminals of specific neurons in the brain. J Neurosci 16: 1990–2001, 1996.[Abstract/Free Full Text]

Rodriguez-Moreno A, Herreras O, and Lerma J. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 19: 893–901, 1997.[CrossRef][Web of Science][Medline]

Saitoh K, Isa T, and Takakusaki K. Nigral GABAergic inhibition upon mesencephalic dopaminergic cell groups in rats. Eur J Neurosci 19: 2399–2409, 2004.[CrossRef][Web of Science][Medline]

Smith Y, Charara A, Hanson JE, Paquet M, and Levey AI. GABAB and group I metabotropic glutamate receptors in the striatopallidal complex in primates. J Anat 196: 555–576, 2000.

Stefani A, Spadoni F, Giacomini P, Lavaroni F, and Bernardi G. The modulation of calcium current by GABA metabotropic receptors in a sub-population of pallidal neurons. Eur J Neurosci 11: 3995–4005, 1999.[CrossRef][Web of Science][Medline]

Takahashi T, Kajikawa Y, and Tsujimoto T. G-Protein-coupled modulation of presynaptic calcium currents and transmitter release by a GABAB receptor. J Neurosci 18: 3138–3146, 1998.[Abstract/Free Full Text]

Thompson SM, Capogna M, and Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci 16: 222–227, 1993.[CrossRef][Web of Science][Medline]

Thompson SM and Gähwiler BH. Comparison of the actions of baclofen at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol 451: 329–345, 1992.[Abstract/Free Full Text]

Waldvogel HJ, Billinton A, White JH, Emson PC, and Faull RLM. Comparative cellular distribution of GABAA and GABAB receptors in the human basal ganglia: immunohistochemical colocalization of the {alpha}1 subunit of the GABAA receptor, and the GABABR1 and GABABR2 receptor subunits. J Comp Neurol 470: 339–356, 2004.[CrossRef][Web of Science][Medline]

White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, and Marshall FH. Heterodimerization is required for the formation of a functional GABAB receptor. Nature 396: 679–682, 1998.[CrossRef][Medline]

Wickman K, Karschin C, Karschin A, Picciotto MR, and Clapham DE. Brain localization and behavioral impact of the G-protein-gated K+ channel subunit GIRK4. J Neurosci 20: 5608–5615, 2000.[Abstract/Free Full Text]

Wilson CJ and Groves PM. Spontaneous firing patterns of identified spiny neurons in the rat neostriatum. Brain Res 220: 67–80, 1981.[CrossRef][Web of Science][Medline]

Wu LG and Saggau P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20: 204–212, 1997.[CrossRef][Web of Science][Medline]

Wu Y, Richard S, and Parent A. The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res 38: 49–62, 2000.[CrossRef][Web of Science][Medline]

Yasumi M, Sato K, Shimada S, Nishimura M, and Tohyama M. Regional distribution of GABA transporter 1 (GAT1) mRNA in the rat brain: comparison with glutamic acid decarboxylase67 (GAD67) mRNA localization. Brain Res Mol Brain Res 44: 205–218, 1997.[Medline]




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
L. Mapelli, P. Rossi, T. Nieus, and E. D'Angelo
Tonic Activation of GABAB Receptors Reduces Release Probability at Inhibitory Connections in the Cerebellar Glomerulus
J Neurophysiol, June 1, 2009; 101(6): 3089 - 3099.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Kaneda, K. Isa, Y. Yanagawa, and T. Isa
Nigral Inhibition of GABAergic Neurons in Mouse Superior Colliculus
J. Neurosci., October 22, 2008; 28(43): 11071 - 11078.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
O. Darbin and T. Wichmann
Effects of Striatal GABAA-Receptor Blockade on Striatal and Cortical Activity in Monkeys
J Neurophysiol, March 1, 2008; 99(3): 1294 - 1305.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Kaneda, P. Phongphanphanee, T. Katoh, K. Isa, Y. Yanagawa, K. Obata, and T. Isa
Regulation of Burst Activity through Presynaptic and Postsynaptic GABAB Receptors in Mouse Superior Colliculus
J. Neurosci., January 23, 2008; 28(4): 816 - 827.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. Kaneda, T. Kita, and H. Kita
Repetitive Activation of Glutamatergic Inputs Evokes a Long-Lasting Excitation in Rat Globus Pallidus Neurons In Vitro
J Neurophysiol, January 1, 2007; 97(1): 121 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Kita, S. Chiken, Y. Tachibana, and A. Nambu
Origins of GABA(A) and GABA(B) receptor-mediated responses of globus pallidus induced after stimulation of the putamen in the monkey.
J. Neurosci., June 14, 2006; 26(24): 6554 - 6562.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneda, K.
Right arrow Articles by Kita, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneda, K.
Right arrow Articles by Kita, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the The American Physiological Society.